Adverum Biotechnologies, Inc. financial data

Symbol
ADVM on Nasdaq
Location
100 Cardinal Way, Redwood City, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 240 % -71.4%
Debt-to-equity 2.19K % +2719%
Return On Equity -3.48K % -3517%
Return On Assets -152 % -181%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 22.1M shares +6.13%
Common Stock, Shares, Outstanding 20.8M shares +106%
Entity Public Float 137M USD -9.95%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 23.5M shares +12.5%
Weighted Average Number of Shares Outstanding, Diluted 23.5M shares +12.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD -100%
Research and Development Expense 129M USD +88.9%
General and Administrative Expense 59.8M USD +6.35%
Operating Income (Loss) -189M USD -52.8%
Nonoperating Income (Expense) 1.2M USD -41.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -131M USD -6.28%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -185M USD -61.4%
Earnings Per Share, Basic -8 USD/shares -21.4%
Earnings Per Share, Diluted -8 USD/shares -21.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 26.1M USD -71.9%
Cash, Cash Equivalents, and Short-term Investments 26.1M USD -83%
Assets, Current 28.9M USD -82.1%
Property, Plant and Equipment, Net 10.5M USD -14.4%
Operating Lease, Right-of-Use Asset 29M USD -13.8%
Other Assets, Noncurrent 2.02M USD +56.5%
Assets 72.4M USD -65.6%
Accounts Payable, Current 12.5M USD +490%
Liabilities, Current 44.7M USD +97.9%
Operating Lease, Liability, Noncurrent 83.1M USD +4.74%
Other Liabilities, Noncurrent 179K USD
Liabilities 128M USD +25.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -440K USD -64.2%
Retained Earnings (Accumulated Deficit) -1.21B USD -18%
Stockholders' Equity Attributable to Parent -55.7M USD -151%
Liabilities and Equity 72.4M USD -65.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -42.8M USD -84%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 31.3M USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 20.8M shares +106%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.5M USD -115%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 28M USD -70.4%
Deferred Tax Assets, Valuation Allowance 232M USD +12.7%
Deferred Tax Assets, Gross 240M USD +11.5%
Operating Lease, Liability 88.9M USD
Payments to Acquire Property, Plant, and Equipment 220K USD +144%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -185M USD -61.9%
Lessee, Operating Lease, Liability, to be Paid 155M USD
Property, Plant and Equipment, Gross 29.2M USD -0.81%
Operating Lease, Liability, Current 5.81M USD +3.51%
Lessee, Operating Lease, Liability, to be Paid, Year Two 15.3M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 13.5M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 66.2M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 15.7M USD
Deferred Tax Assets, Operating Loss Carryforwards 137M USD +7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 27.2M USD +19.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 16.1M USD
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 7.99M USD -15.5%
Share-based Payment Arrangement, Expense 10.8M USD -28.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%